Emerson Andrew bought IDXX
February 14, 2026 · Form 4 insider transaction
Emerson Andrew bought 65 shares of IDEXX Laboratories, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
65
Price
$0.00
Total value
N/A
InsiderEmerson Andrew
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 14, 2026
Filing dateFebruary 17, 2026
Shares owned after4,345
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's separation of service with the Issuer or a date specified by the reporting person.